COEP
Coeptis Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$10.99
−8.57%Margins
Gross margin
87.2%
EBITDA margin
-769.0%
EBIT margin
-912.4%
Net margin
-839.7%
FCF margin
-565.5%
-57.0%
Return on equity
-60.0%
Return on assets
-60.9%
Return on invested capital
0.07x
Asset turnover
-$8.0M
Cash from operations
$1.11
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026